Lv1
80 积分 2025-02-23 加入
Enhancing immunotherapy with tumour-responsive nanomaterials
9天前
已完结
Overcoming therapeutic resistance in oncology: The prospects of inorganic nanotheranostics
9天前
已关闭
Immunity‐Modulating Metal‐Based Nanomaterials for Cancer Immunotherapy
10天前
已完结
Mechanisms of Ovarian Cancer-Associated Cachexia
12天前
已完结
Mir-338-3p Increases the Sensitivity to Oxaliplatin via Reversing EpithelialmesenchymalTransition in Hepatocellular Carcinoma Cells
24天前
已完结
MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells
24天前
已完结
Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors
27天前
已完结
YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy
28天前
已完结
Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1–AKT interaction
28天前
已关闭
Biologically Active Arborinane-Type Triterpenoids and Anthraquinones from Rubia yunnanensis
1个月前
已完结
皖公网安备34019202002308
